Oramed Pharmaceuticals (ORMP) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed Whitehawk Therapeutics (WHWK) over the past year, gaining 75.7% versus a gain of 62.9%. Over five years, ORMP leads with a -81.0% price change compared with -87.2% for WHWK. Whitehawk Therapeutics is the larger company by market cap ($197.8 million vs $174.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ORMP | WHWK |
|---|---|---|
| Share price | $4.20 | $3.47 |
| Market cap | $174.71M | $197.82M |
| 1-day change | -3.89% | +1.76% |
| YTD return | +47.37% | +43.39% |
| 1-year return | +75.73% | +62.91% |
| 5-year return | -80.96% | -87.25% |
| P/E ratio (TTM) | 1.02 | — |
| EPS (TTM) | $4.13 | $-1.14 |
| Dividend yield | 5.71% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.47 | $5.50 |
| 52-week low | $2.09 | $1.87 |
| Distance from 52-week high | -23.22% | -36.85% |
| Analyst consensus | none | buy |
| Avg. price target upside | +66.67% | +122.19% |
| Average volume | 190.50K | 367.72K |
| Shares outstanding | 41.60M | 57.01M |
| Employees | — | 32 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed WHWK by 12.8 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.71% vs 0.00%).
- The two companies sit in different sectors: Oramed Pharmaceuticals in Health Care and Whitehawk Therapeutics in Healthcare.
About Oramed Pharmaceuticals
ORMP stock →Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
Health Care · Biotechnology: Pharmaceutical Preparations
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Healthcare · Biotechnology · 32 employees
ORMP vs WHWK FAQ
Which is bigger, Oramed Pharmaceuticals or Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $197.82M compared with $174.71M for Oramed Pharmaceuticals (ORMP).
Which stock has performed better over the past year, ORMP or WHWK?
ORMP returned +75.73% over the past 12 months, compared with +62.91% for WHWK (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Oramed Pharmaceuticals or Whitehawk Therapeutics?
Oramed Pharmaceuticals pays a dividend yielding 5.71%, while Whitehawk Therapeutics does not currently pay a regular dividend.
Are Oramed Pharmaceuticals and Whitehawk Therapeutics in the same industry?
No. Oramed Pharmaceuticals is in the Health Care sector, while Whitehawk Therapeutics is in Healthcare.